摘要
目的观察喘可治注射液及自体血穴位注射治疗支气管哮喘的临床疗效。方法将150例患者随机分为喘可治治疗组50例,自体血治疗组50例,西医常规治疗对照组50例,对照组仅采用抗炎、化痰及解痉平喘等西医常规治疗,治疗组在西医常规治疗的基础上,分别运用喘可治注射液、自体血穴位注射外治疗法,以60 d为治疗周期判断疗效。结果 3组治疗结束后,哮喘控制水平、血清特异性总IgE、嗜酸性粒细胞计数和FEV1%预计值都得到了明显改善,3组与治疗前比较差异均有统计学意义(P<0.05);同时治疗组与同期对照组比较,差异有统计学意义(P<0.05)。结论喘可治注射液、自体血穴位注射治疗支气管哮喘临床疗效确切。
Objective To observe the chuankezhi（CKZ）/autologous blood injection and the therapeutic effect of acupoint-injection for treatment of bronchial asthma.Methods 150 cases patients random is divided into CKZ treatment group 50 cases,body blood treatment group 50 cases,western general treatment control group 50 cases,the control group was trested with routine weston medicine alone,treatment group was trested with routine weston medicine combined with CKZ or body blood point-injection.Results three groups after the end of treatment,asthma control levels,total serum specific IgE and eosinophil count and FEV1% values are expected to be markedly improved,three groups are statistically compared with before treatment（P＆lt;0.05）,while treatment group compared with the control group for the same period,there was a statistically significant difference（P＆lt;0.05）.Conclusion CKZ/ autologous blood injection and the therapeutic effect of acupoint-injection for treatment of bronchial asthma precisely.
出处
《湖南中医药大学学报》
CAS
2013年第6期72-74,共3页
Journal of Hunan University of Chinese Medicine
